GlassScriptPhysician profile
Brent Taiting Xia
NPI 1306289871
$3,095.33
in general payments reported to CMS, 2019-2025
15 companies · $2,298 in 2025
The $2,298 reported for 2025 was more than what 83% of Surgical Oncology providers received nationally (typical 2025 total: $288).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $97.42 · 2022: $124 · 2023: $208 · 2024: $368 · 2025: $2,298.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,184 · Travel and Lodging: $689.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,184.46 |
| Travel and Lodging | $688.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Histosonics, INC. | $1,173.35 | 2025 | |
| E.R. Squibb & Sons, L.L.C. | $333.55 | 2023-2024 | Opdivo |
| Medtronic, INC. | $280.68 | 2025 | Signia |
| Siemens Medical Solutions USA, INC. | $149.84 | 2025 | Microthermx Microwave Ablation System |
| Incyte Corporation | $132.31 | 2025 | Zynyz |
| Astrazeneca Pharmaceuticals LP | $125.76 | 2025 | |
| Boston Scientific Corporation | $124.90 | 2025 | Therasphere Y90 Glass Microspheres 10 Gbq |
| Alcresta Therapeutics, INC. | $124.48 | 2022 | |
| Solventum Corporation | $123.49 | 2025 | V.A.C. Veraflo |
| Davol INC. | $115.48 | 2024 | Phasix Mesh |
| Ipsen Biopharmaceuticals, INC | $110.33 | 2025 | Onivyde |
| Abbvie INC. | $97.42 | 2021 | |
| Intera Oncology, INC | $81.58 | 2024 | Intera |
| Advanced Critical Devices, INC. | $76.88 | 2025 | Vascular Products |
| Medical Device Business Services, INC. | $45.28 | 2024 | Harmonic |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brent Xia listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.